Pharmaceutical companies are experiencing a significant change because of the shift in drug development toward more complex and expensive cell therapies with a focus on rare diseases.
Advancements open a new range of applications to the use of intelligent, networked valve manifold I/O. The new hardware makes it possible to gain advantages in labor savings and diagnostic capability.
Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.